Home
About Us
Team
Investment Focus
Laboratory Products
Laboratory Services
Contract Manufacturing
Pharma Services
Specialty Pharma
Portfolio
News
Contact
News
October 31, 2019
October 31, 2019
Mesa Labs Acquires Gyros Protein Technologies
October 30, 2019
October 30, 2019
Arranta Bio announces $82M in new funding, and a strategic partnership with Thermo Fisher Scientific
October 17, 2019
October 17, 2019
Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners
October 7, 2019
October 7, 2019
New England Peptide Receives Growth Equity Investment From Ampersand Capital Partners
September 30, 2019
September 30, 2019
N2 Biomedical Appoints Victor Nunes and Dean Schauer to Board of Directors
July 15, 2019
July 15, 2019
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
June 18, 2019
June 18, 2019
Ampersand Completes Growth Equity Investment in N2 Biomedical
June 6, 2019
June 6, 2019
NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology Franchise by Acquiring PAIRimmune
May 29, 2019
May 29, 2019
Ampersand Capital Partners to Acquire Vibalogics GmbH
May 8, 2019
May 8, 2019
Ampersand Capital Partners completes Growth Equity Investment in Transplantation Diagnostic firm GenDx
Prev page
1
2
3
4
...
11
Next page
